# Surgical Menopause and Bilateral Oophorectomy

> NEET-PG Obstetrics and Gynaecology notes on surgical menopause after oophorectomy, covering abrupt symptoms, cardiovascular and bone risk and HRT decisions.

- Canonical URL: https://prepelephant.com/topics/neet-pg/obstetrics-and-gynaecology/surgical-menopause-and-bilateral-oophorectomy
- Exam / course: NEET-PG · Subject: Obstetrics and Gynaecology
- Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team
- First published: 2026-10-14
- Last updated: 2026-10-14
- Reference basis: Williams Gynecology; Speroff's Clinical Gynecologic Endocrinology and Infertility; Dutta's Textbook of Gynecology
- How to cite: "Surgical Menopause and Bilateral Oophorectomy", PrepElephant, https://prepelephant.com/topics/neet-pg/obstetrics-and-gynaecology/surgical-menopause-and-bilateral-oophorectomy

## Direct answer

Surgical menopause is the sudden loss of ovarian oestrogen that follows bilateral oophorectomy before natural menopause. Symptoms arrive abruptly rather than declining over years, with severe vasomotor and genitourinary effects, and the woman faces long-term risks of cardiovascular disease and osteoporosis, so hormone replacement is usually offered unless contraindicated.

## What you must remember

- **Onset:** Symptoms appear abruptly within days or weeks, unlike the gradual decline of natural menopause.
- **Vasomotor symptoms:** Hot flushes and night sweats are typically severe, and sleep and mood are often disturbed.
- **Genitourinary effects:** Vaginal dryness, dyspareunia and urinary symptoms reflect oestrogen withdrawal from the urogenital tract.
- **Cardiovascular risk:** Early loss of ovarian function is linked to higher coronary risk, which hormone therapy started early may reduce.
- **Bone:** Accelerated bone loss raises the risk of osteoporosis and fracture.
- **Cognition and mood:** Low mood, anxiety and cognitive complaints are common and need assessment.
- **Hormone replacement:** Systemic oestrogen replaces the lost hormone, with a progestogen added if the uterus is intact.

## A decision pathway for hormone replacement

A 42-year-old woman has undergone bilateral oophorectomy for a benign ovarian mass and asks whether she should take hormones. The decision follows a fixed sequence of assessment, with the risks weighed against the symptoms.

1. **Establish the indication:** Confirm that the oophorectomy was bilateral and that symptoms relate to oestrogen loss rather than another cause such as thyroid disease.
2. **Assess the uterus:** Use an oestrogen-progestogen regimen if the uterus is intact, and oestrogen alone after hysterectomy.
3. **Weigh risks and benefits:** Discuss symptom relief against the risks of venous thromboembolism, breast cancer and stroke, which depend on age, time since surgery and personal history.
4. **Start early when suitable:** Starting near the time of surgery is generally favoured in women without contraindications, because earlier initiation is linked to better outcomes.
5. **Continue to the natural menopausal age:** Standard advice is to continue therapy until around the average age of natural menopause, with benefit and risk reviewed at intervals.
6. **Monitor bone and cardiovascular health:** Assess bone density, lipids and blood pressure, and adjust the regimen as needed.
7. **Consider non-hormonal options:** Women who cannot take hormones are offered non-hormonal drugs and local vaginal therapy for specific symptoms.

## Where the exam tries to catch you

Vignettes often test the difference between surgical and natural menopause and the need for a progestogen.

- **Trap:** Assuming surgical menopause behaves like natural menopause. — **Correct:** Symptoms are abrupt and often more severe, and the long-term risks are greater.
- **Trap:** Giving oestrogen alone to a woman with an intact uterus. — **Correct:** Oestrogen unopposed by a progestogen causes endometrial hyperplasia, so a progestogen is added.
- **Trap:** Withholding hormone therapy from all women because of their age. — **Correct:** Hormone therapy is individualised, and early initiation in suitable women is generally favoured over no treatment.
- **Trap:** Ignoring bone health after oophorectomy. — **Correct:** Bone loss accelerates after oophorectomy, so density, calcium and vitamin D intake are assessed.

## Frequently asked questions

### What is surgical menopause?
Surgical menopause is the sudden loss of ovarian oestrogen after bilateral oophorectomy before natural menopause. Symptoms appear abruptly, unlike the gradual decline seen in natural menopause.

### Why are symptoms more severe after bilateral oophorectomy?
Symptoms are often more severe because oestrogen falls abruptly rather than declining over several years. The body has no time to adapt, so vasomotor, genitourinary and mood symptoms can be intense.

### Does hormone replacement therapy reduce cardiovascular risk after oophorectomy?
Hormone replacement therapy started near the time of surgery may reduce cardiovascular risk in suitable women, while starting it much later offers less benefit. The decision depends on age, personal history and the balance of risks for each woman.

### Which hormone regimen is used after bilateral oophorectomy in a woman with an intact uterus?
An oestrogen-progestogen regimen is used because the progestogen protects the endometrium from hyperplasia caused by unopposed oestrogen. Oestrogen alone is reserved for women who have had a hysterectomy.

### Why is bone health assessed after bilateral oophorectomy?
Bone loss is accelerated after bilateral oophorectomy because oestrogen protects bone, so the risk of osteoporosis and fracture rises. Bone density assessment and attention to calcium and vitamin D intake are recommended.